Lakeshore555 says
" No reason at all. If they want a shell to get listed on an exchange, they merely need to find a Dignyte somewhere that has no debt and hasn't issued all of its authorized shares."
Wolf Says
If that was the case, then why did William give Mac the Dignyte shell for E Wellness? We have already shown you the the 19 year old CEO (Andreas McRobbie Johnson of dignyte (now former CEO) and his mother Julie Johnson who has been an associate of William's before he merged into Provista Life Sciences. Then the obvious is that the Radient Shell is more valuable then Dignyte you understand...Wolf..Julie Johnson was the communication Manager for GCDX..It appears she just got promoted you understand..Wolfie
Lakeshore555 says
Gartner may be a biotech genius and a business wizard.
But you say he already has the license to manufacture and sell DR-70, and in six weeks when the patent expires he won't even need THAT.
He already has Radient's only asset, as short-lived as that asset may be. So there is NO REASON for Gartner or Provista or anyone else to acquire RXPC stock or take over Radient as a company. No reason at all. If they want a shell to get listed on an exchange, they merely need to find a Dignyte somewhere that has no debt and hasn't issued all of its authorized shares.
